Pharmacy
NEC joins €6.5m European project using AI for pandemic vaccine design
November 6, 2026EU, Immunology, Infections and infestations, Pharmacy, Vaccine, collaboration, pandemic
NEC OncoImmunity, a subsidiary of NEC Corporation, is leading the AI-powered antigen prediction and vaccine design work in a four-year …
The evidence bar impacting UK medical cannabis access
November 6, 2026Cannabinoids, Chronic Diseases, Legislation, NICE, Pharmacy, chronic pain, drug approval
By Mike Morgan-Giles Private prescribing of cannabis-based medicines in the UK has more than doubled in a year. Getting the …
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026Cardiology, EnteroBiotix, GSK, Obesity, Pharmacy, appointments, approvals
EnteroBiotix has appointed Dr Murray Stewart, former Chief Medical Officer at GSK and Rhythm Pharmaceuticals, to its Board of Directors. …
AI: an early warning system for patient safety
November 3, 2026AI, Cardiology, Diabetes, Diagnostics, Obesity, Pharmacy, chronic disease, chronic pain, pharmacovigilance
By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While every medicine undergoes rigorous clinical …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
October 27, 2026Asthma & COPD, COPD, EMA, EU, Pharmacy, asthma
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European Commission as a maintenance treatment for asthma in …
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
October 27, 2026Chronic Diseases, EMA, Pain, Pharmacy, drug development, regulatory
Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …
New CCO Ogburn joins Cori Clinical
October 21, 2026Corporate, Data Capture, Pharmacy, pharmaceutical, regulatory
Cori Clinical has announced the appointment of Dr Emma Ogburn as Chief Clinical Officer. She joins Cori’s founding team of …
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026Consultancy, Diagnostics, Pharmacy, drug development, life sciences, regulatory affairs
Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs. Hayes …
Cori Clinical raises US$4m to expand AI platform for clinical trial design
October 14, 2026AI, Data Capture, Pharmacy, clinical data, clinical trial design, regulatory affairs
Cori Clinical has raised US$4m in a seed funding round to expand its AI platform for clinical trial design and …
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026Biotechnology, CDMO, Pharmacy, acquisitions, drug substance development
Ofichem has agreed to acquire Kinentia Biosciences, a US drug substance contract development and manufacturing organisation (CDMO), in a deal …
Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster
October 11, 2026Licenses/Quality Standards, Marketing, Sales & Marketing Training AI, Devices, Diagnostics, Hospital Management, Pharmacy, biopharma, medical adoption, pharmaceutical
By Chris Moore Commercial engagement in biopharma used to centre largely on direct conversations between sales reps and physicians or …
ESTEVE CDMO adds $17.5m to Illinois expansion
October 6, 2026Clinical trials supplies & documentation logistics, Logistics & Distribution, Manufacturing and Production, Warehousing & distribution API manufacture, Corporate, Pharmacy, investment, laboratory, pharma production
ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its Morton Grove facility in Illinois, …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
October 4, 2026Biopharmaceuticals, Pharmacy, cell culture, manufacturing
Brenntag Pharma and dsm-firmenich have entered a long-term global distribution partnership covering GMP-grade vitamins for biopharmaceutical manufacturing. Under the agreement, …
Turning a 10-Year Vision into a 10-Year Plan
October 27, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …
Novel excipients: the key to unlocking drug innovation
October 6, 2025Business Services Lubrizol, Pharmacy
ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
